🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Myeloproliferative Neoplasms (MPNs)

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms NCT06063486Phase 22 sites📍 Los Angeles📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-co… Myeloproliferative Neoplasms (MPNs) Patient Registry NCT02760238n/a1 site📍 Toronto University Health Network, Toronto · Tests: Observational A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) NCT06661915Phase 231 sites📍 Irvine📍 Orange📍 Palo Alto National Cancer Institute (NCI) · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Decitabine and Cedazuridine, Iadademstat A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms NCT07849231Phase 14 sites📍 Liverpool📍 Sydney📍 Melbourne Damora Therapeutics · Tests: DMR-001, Ruxolitinib Selumetinib and Azacitidine in High Risk Chronic Blood Cancers NCT03326310Phase 11 site📍 Chicago University of Chicago · Tests: Azacitidine, Selumetinib MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225n/a2 sites📍 Chicago📍 New York MPN Research Foundation Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation NCT06291987Phase 12 sites📍 Chicago📍 Milwaukee University of Chicago · Tests: Ivosidenib, Ruxolitinib A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms NCT07469891Phase 118 sites📍 Los Angeles📍 Denver📍 Coral Springs Prelude Therapeutics Incorporated · Tests: PRT12396 Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs NCT05423691Phase 14 sites📍 Sacramento📍 New York📍 The Bronx Cellenkos, Inc. · Tests: CK0804
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy